Oct 16, 2026 01:00AM
Oct 16, 2026 01:00AM
Oct 10, 2026 05:40PM
Oct 9, 2026 01:01AM
Oct 9, 2026 01:00AM
Oct 1, 2026 02:00AM
Oct 1, 2026 01:00AM Genentech’s Giredestrant Combination Significantly Improved Progression-Free Survival in ER-positive Advanced Breast Cancer in Phase III evERA Data Published in The New England Journal of Medicine
Sep 30, 2026 01:00AM
Sep 17, 2026 01:00AM
Sep 10, 2026 01:11AM
Sep 10, 2026 01:11AM
Aug 26, 2026 02:52PM
Aug 26, 2026 02:52PM
Aug 24, 2026 07:00AM Roche receives FDA clearance for Elecsys® pTau217, advancing Alzheimer's disease assessment across primary and specialty care
Jul 24, 2026 08:31AM
Jul 24, 2026 08:30AM
Jul 22, 2026 09:00AM
Jul 15, 2026 01:01AM
Jul 15, 2026 01:00AM
Jul 2, 2026 01:10AM
Jun 30, 2026 01:09AM FDA grants priority review to Genentech's Enspryng for thyroid eye disease
Jun 30, 2026 01:09AM
Jun 18, 2026 01:00AM
Jun 18, 2026 01:00AM
Jun 11, 2026 01:05AM
Jun 11, 2026 01:05AM
Jun 2, 2026 07:00AM
Jun 2, 2026 01:05AM FDA Accepts New Drug Application for Genentech’s Giredestrant in ER-Positive Early-Stage Breast Cancer, the First and Only Oral SERD With Positive Phase III Results in the Curative Setting
May 19, 2026 01:05AM
May 19, 2026 01:05AM
May 15, 2026 12:45PM
May 15, 2026 12:45PM
Apr 30, 2026 01:00AM
Apr 24, 2026 02:49AM
Apr 22, 2026 08:30AM Advancing Drug Pipelines Drive Biotech Valuations as Scientific Progress Gains Financial Recognition
Apr 21, 2026 07:15PM
Apr 21, 2026 11:45AM
Apr 21, 2026 01:00AM
Apr 16, 2026 07:00AM
Mar 30, 2026 09:01AM
Mar 30, 2026 09:00AM
Mar 19, 2026 02:11PM Cantor Fitzgerald: 'We now expect apitegromab to have near complete market share'
Mar 18, 2026 09:00AM
Mar 9, 2026 02:10AM
Mar 6, 2026 08:45AM
Mar 2, 2026 01:10AM
Feb 20, 2026 02:00AM
Feb 20, 2026 02:00AM
Feb 20, 2026 01:05AM FDA Accepts New Drug Application for Genentech’s Giredestrant in ESR1-Mutated, ER-Positive Advanced Breast Cancer
Feb 16, 2026 01:00AM

334,274 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All